
9 Apr 2025
New Criteria Improve Diagnosis of IgG4-Related Arterial Disease
Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.

9 Apr 2025
Phototherapy Plus Antioxidants Top Vitiligo Treatments
In a new network meta-analysis evaluating treatments for vitiligo, researchers have identified the most effective combinations of phototherapy and topical therapies, offering clinicians fresh insights into optimizing patient outcomes.

8 Apr 2025
Inspire Study Links Spinal Stimulation to Recovery in Diabetic Neuropathy: AAN 2025
At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, researchers presented late-breaking data from the Inspire Study, a trial exploring spinal cord stimulation (SCS) as a holistic treatment for painful diabetic peripheral neuropathy (pDPN).

8 Apr 2025
Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025
New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.